US Patent Litigations are now available. Check here

Explore Lajolla Institute For Allergy And Immunology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 17, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2207597Feb 19, 2020Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment1